Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson weekly Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E23.84 EPS (ttm)6.25 Insider Own0.08% Shs Outstand2.63B Perf Week3.70%
Market Cap391.38B Forward P/E16.56 EPS next Y9.00 Insider Trans-2.03% Shs Float2.63B Perf Month7.58%
Income16.69B PEG5.44 EPS next Q1.83 Inst Own70.10% Short Float0.55% Perf Quarter-0.37%
Sales80.86B P/S4.84 EPS this Y0.50% Inst Trans-0.19% Short Ratio2.12 Perf Half Y1.15%
Book/sh24.49 P/B6.08 EPS next Y12.35% ROA10.60% Target Price166.18 Perf Year6.90%
Cash/sh11.72 P/C12.71 EPS next 5Y4.38% ROE27.40% 52W Range109.16 - 157.00 Perf YTD2.15%
Dividend4.04 P/FCF49.02 EPS past 5Y-0.20% ROI17.30% 52W High-5.10% Beta0.67
Dividend %2.71% Quick Ratio1.20 Sales past 5Y2.00% Gross Margin65.80% 52W Low36.50% ATR2.48
Employees132200 Current Ratio1.50 Sales Q/Q1.70% Oper. Margin23.60% RSI (14)60.69 Volatility1.43% 1.57%
OptionableYes Debt/Eq0.59 EPS Q/Q102.80% Profit Margin21.00% Rel Volume1.06 Prev Close149.00
ShortableYes LT Debt/Eq0.51 EarningsOct 13 BMO Payout60.80% Avg Volume6.87M Price149.00
Recom1.90 SMA201.77% SMA502.33% SMA2002.98% Volume0 Change0.00%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Dec-04-20 08:37AM  
06:30AM  
06:11AM  
Dec-03-20 11:42PM  
05:45PM  
05:42PM  
04:05PM  
02:58PM  
12:50PM  
10:59AM  
10:08AM  
07:16AM  
07:00AM  
Dec-02-20 02:35PM  
09:09AM  
07:35AM  
06:52AM  
06:20AM  
06:08AM  
Dec-01-20 04:55PM  
03:07PM  
02:23PM  
11:15AM  
09:52AM  
09:19AM  
08:00AM  
06:30AM  
Nov-30-20 05:33PM  
04:54PM  
10:45AM  
Nov-29-20 01:34PM  
11:24AM  
Nov-28-20 06:17AM  
Nov-27-20 04:41PM  
01:10PM  
09:21AM  
06:20AM  
Nov-25-20 01:06PM  
10:16AM  
07:36AM  
06:43AM  
Nov-24-20 05:25PM  
01:30PM  
12:10PM  
12:05PM  
11:36AM  
11:27AM  
09:21AM  
Nov-23-20 06:48PM  
12:45PM  
11:12AM  
10:59AM  
09:46AM  
03:43AM  
02:44AM  
Nov-22-20 05:12PM  
02:01PM  
09:15AM  
Nov-21-20 07:04AM  
Nov-20-20 04:25PM  
12:50PM  
11:25AM  
10:15AM  
09:54AM  
09:45AM  
09:44AM  
07:55AM  
06:09AM  
05:30AM  
Nov-19-20 05:06PM  
04:51PM  
10:26AM  
10:00AM  
02:50AM  
Nov-18-20 03:44PM  
07:34AM  
06:46AM  
05:50AM  
05:21AM  
01:29AM  
Nov-17-20 11:44PM  
02:20PM  
12:29PM  
09:51AM  
08:00AM  
06:38AM  
Nov-16-20 06:03PM  
02:39PM  
01:54PM  
01:04PM  
12:13PM  
10:07AM  
10:04AM  
09:50AM  
08:45AM  
08:18AM  
02:31AM  
Nov-15-20 03:00PM  
06:15AM  
06:11AM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Option Exercise90.4419,2241,738,61975,039Feb 25 04:23 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Sale147.9639,2245,803,58335,815Feb 25 04:23 PM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM